Financhill
Sell
18

SWTX Quote, Financials, Valuation and Earnings

Last price:
$34.12
Seasonality move :
5.59%
Day range:
$32.83 - $38.60
52-week range:
$28.21 - $62.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.36x
P/B ratio:
5.78x
Volume:
3.5M
Avg. volume:
2.3M
1-year change:
-16.06%
Market cap:
$2.8B
Revenue:
$191.6M
EPS (TTM):
-$3.48

Earnings Data

Next earnings date for SWTX
May 02
2025
Most recent earnings per share
-$1.04
Missed by $0.33
(Feb 20/2025)
Consensus Estimate
-$0.71
(Feb 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SWTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $75.3M -- -- -$0.73 --
05/02/2025 Q1 $66.9M -- -- -$0.74 --
02/20/2025 Q4 $60.5M $61.5M -$1.04 -$0.71 -$0.33
11/12/2024 Q3 $55.1M $49.3M -$0.72 -$0.76 $0.04
08/07/2024 Q2 $34.6M $59.7M -$0.54 -$1.07 $0.53
05/02/2024 Q1 $13.1M $21M -$1.18 -$1.06 -$0.12
02/27/2024 Q4 $903.3K $5.4M -$1.45 -$1.10 -$0.35
11/02/2023 Q3 -- -- -$1.27 -$1.22 -$0.05
08/02/2023 Q2 -- -- -$1.25 -$1.08 -$0.17
05/03/2023 Q1 -- -- -$1.18 -$1.10 -$0.08
02/28/2023 Q4 -- -- -$1.17 -$1.01 -$0.16
11/03/2022 Q3 -- -- -$1.37 -$1.05 -$0.32
08/04/2022 Q2 -- -- -$1.41 -$1.15 -$0.26
05/05/2022 Q1 -- -- -$1.26 -$1.02 -$0.24
02/24/2022 Q4 -- -- -$1.16 -$0.73 -$0.43
11/04/2021 Q3 -- -- -$0.84 -$0.67 -$0.17
08/04/2021 Q2 -- -- -$0.97 -$0.69 -$0.29
05/06/2021 Q1 -- -- -$0.62 -$0.44 -$0.18
02/25/2021 Q4 -- -- $0.30 $0.08 $0.22
11/12/2020 Q3 -- -- -$0.51 -$0.43 -$0.08
08/12/2020 Q2 -- -- -$0.47 -$0.35 -$0.12
05/12/2020 Q1 -- -- -$0.37 -$0.35 -$0.02
03/12/2020 Q4 -- -- -$0.38 -$0.32 -$0.06
11/12/2019 Q3 -- -- -$1.77 -$0.41 -$1.36

SpringWorks Therapeutics Earnings Questions

  • How Much did SpringWorks Therapeutics Generate in Revenue Last Quarter?

    SpringWorks Therapeutics reported $61.5M worth of top line sales in its most recent quarter.

  • Did SpringWorks Therapeutics Beat Earnings Last Quarter?

    SpringWorks Therapeutics announced earnings per share of -$1.04 which represents a miss of analyst forecast a -$0.71 per share.

  • Is SpringWorks Therapeutics Profitable?

    SpringWorks Therapeutics reported $56M that represents $0.75 per share over the last quarter.

  • What is the Analyst Consensus for SpringWorks Therapeutics EPS Next Year?

    SpringWorks Therapeutics's earnings are forecast to decrease from -$3.48 per share to -$3.16 per share next year representing a decrease of -32.97%.

  • When is SpringWorks Therapeutics's Earnings Date?

    SpringWorks Therapeutics's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 21.3% over the past day.

Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 18.53% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 18.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock